Skip to content

Early Recovery After Cesarean Delivery - Maternal Glucose Homeostasis Following Preoperative Glucose Dose

Early Recovery After Cesarean Delivery - Maternal Glucose Homeostasis Following Preoperative Glucose Dose in Diabetic Parturients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05396378
Enrollment
150
Registered
2022-05-31
Start date
2023-07-01
Completion date
2023-12-31
Last updated
2023-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications, Gestational Diabetes

Brief summary

Diabetic parturients planned for cesarean delivery will be recruited for the study. They will receive a fixed glucose dose to mimize the effects of fasting preoperatively and their blood glucose levels will be monitored.

Detailed description

Informed voluntary parturients planned for cesarean delivery will be informed about the study. The parturients will get prepacked glucose drink containing 100 g and 50 g glucose, respectively. They will consume the 100 g of glucose the night before the planned operation and the 50 g on the morning of the planned cesarean delivery. Their blood glucose level will be monitored by percutaneous continuous blood glucose monitoring every 30 minutes for 2 hours following the glucose dose in the evening and for four hours in the morning of the operation. The subjective well being of these parturients will be also qualitatively assessed.

Interventions

DIETARY_SUPPLEMENTOral glucose in liquid form

A glucose containing drink that has a fixed dose of 25 g of glucose per can.

Sponsors

Women's Hospital HUS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years

Inclusion criteria

* Volunteers to participate in the study * Diabetes, either gestational or type II * Planned for cesarean delivery

Exclusion criteria

* Type I diabetes

Design outcomes

Primary

MeasureTime frameDescription
Increase of blood glucose following the oral glucose dose4 hoursThe effect of oral glucose dose on the parturient's blood glucose level (mM)

Secondary

MeasureTime frameDescription
Maternal subjective well being after oral glucose dose during the preoperative fasting period4 hourssubjective assessment by the parturient (categorial)

Countries

Finland

Contacts

Primary ContactMarja Kaijomaa, MD PhD
marja.kaijomaa@hus.fi358504279650
Backup ContactAntti Vaananen, MD PhD
antti.vaananen@hus.fi358504271850

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026